News | November 22, 2022
Natural Biogenex completes its maiden fund-raise of Rs 18.75 Cr
The proceeds from this fund-raise will be deployed in financing the project requirements of the API business
The proceeds from this fund-raise will be deployed in financing the project requirements of the API business
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
The acquisition is for an enterprise value of Rs. 218 crores
Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.
The agreement provides for acquisition of 13,50,000 equity shares of Rs. 100 each constituting 50% of the total equity share capital
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
The existing hospital premises has the scope to further scale up the bed capacity as and when required in the future with minimal Capex.
The company shall be engaged in the business of manufacturing of pharmaceutical, bio-pharmaceutical and biological products of any kind
Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines
Subscribe To Our Newsletter & Stay Updated
